Pharmena S.A. Logo

Pharmena S.A.

PHR | WAR

Overview

Corporate Details

ISIN(s):
PLPHRMN00011
LEI:
259400RHT936BBKW0955
Country:
Poland
Address:
ŁÓDŹ GDAŃSKA 47/49, 90-729 ŁÓDŹ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pharmena S.A. is a publicly traded biotechnology and specialty healthcare company focused on the development, manufacturing, and commercialization of innovative products. The company's portfolio is centered around its proprietary and patented active substance, the 1-MNA molecule (marketed as Regen7 molecule®), a naturally occurring niacin metabolite. This molecule is designed to optimize cellular NAD+ levels, which are linked to cellular health and aging. Pharmena's key product lines include dermocosmetics and dietary supplements sold under the Endotelio brand. The company operates in European and North American markets and is also engaged in research and development for new applications of its core technology, including medical devices for wound healing.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Pharmena S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-16 10:53
Regulatory News Service
Rozpoczęcie współpracy z Shop Apotheke w zakresie sprzedaży suplementów diety w…
Polish 1.2 KB
2025-07-07 10:12
Regulatory News Service
Zawarcie umowy na opracowanie dokumentacji oraz wytworzenie serii walidacyjnych…
Polish 2.0 KB
2025-06-25 16:52
Declaration of Voting Results & Voting Rights Announcements
PHR_Wykaz akcjonariuszy posiad. pow. 5% głosów na ZWZ w dniu 25 06 2025
Polish 50.1 KB
2025-06-25 16:52
Major Shareholding Notification
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na ZWZ w dniu 25…
Polish 525 bytes
2025-06-25 16:51
Board/Management Information
250625_Informacja dot Jacka Szwajcowskiego
Polish 306.7 KB
2025-06-25 16:51
Board/Management Information
250625_Informacja dot Zbigniewa Molenda
Polish 224.2 KB
2025-06-25 16:51
Board/Management Information
250625_Informacja dot. Anny Paczkowskiej
Polish 239.0 KB
2025-06-25 16:51
Board/Management Information
250625_Informacja dot Tomasz Filipiak
Polish 192.5 KB
2025-06-25 16:51
Board/Management Information
250625_Informacja dot Agnieszki Dziki
Polish 146.7 KB
2025-06-25 16:51
Board/Management Information
250625_Informacja dot Jacka Dauenhauera
Polish 225.0 KB
2025-06-25 16:51
Post-Annual General Meeting Information
Powołanie członków Rady Nadzorczej na nową kadencję - Content (PL)
Polish 1.3 KB
2025-06-25 16:50
Post-Annual General Meeting Information
Treść uchwał podjętych przez ZWZ PHARMENA S.A. w dniu 25 06 2025
Polish 176.8 KB
2025-06-25 16:50
Post-Annual General Meeting Information
Treść uchwał podjętych przez ZWZ PHARMENA S.A. w dniu 25.06.2025 r. - Content (…
Polish 822 bytes
2025-05-29 14:57
Board/Management Information
zal03_Oswiadczenie_Jacek_Szwajcowski.pdf
Polish 646.9 KB
2025-05-29 14:57
Board/Management Information
zal07_250529_Informacja_dot_Jacka_Szwajcowskiego.pdf
Polish 146.5 KB

Automate Your Workflow. Get a real-time feed of all Pharmena S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharmena S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK